AI & Machine Learning

A Singaporean firm debuts an autonomous finishing fleet in North America, promising its 'Physical AI' can solve labor shortages and slash building costs.

Dr. Mark Leenay joins Cohere Health's board, a strategic move to blend deep clinical and health plan expertise with the firm's advanced AI platform.

A new animated video, voiced by a father and his daughter, offers hope and understanding to children battling a rare and life-threatening liver disease.

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

AI networking specialist Upscale AI deepens its alliance with the SONiC Foundation, betting on open source to challenge proprietary systems in AI infrastructure.

For the 11th straight year, OTAVA lands on CRN's prestigious MSP 500 list. We explore how its focus on security, compliance, and a human-first approach sets it apart.

A new multi-year deal between a top gym and gear brand aims to redefine the climbing experience, fueled by the sport's growing Olympic spotlight.

The $180B US landscaping industry is a mess of 700k operators. For businesses, this means risk. A new managed service model aims to bring order.

FreeLegalMotions.com launches to help inmates navigate the justice system, born from a case exposing alleged judicial misconduct and constitutional violations.

With over 99% creditor approval, Advantage Solutions restructures its debt, gaining time but facing higher costs and a skeptical stock market.

With a new CRO and a major retail push, can the values-led organic drink company replicate its foodservice success against CPG giants? We investigate.

As businesses struggle with unreliable AI, Collate launches a new platform to give models a deep understanding of enterprise data, aiming to build trust.

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

A student stock competition turns into real-world opportunity, as a Moomoo and W!se partnership awards thousands to NYC schools and their top students.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

An InsurTech spin-off is slashing costs and speeding up agent onboarding, setting a new benchmark for a legacy industry resistant to change.

With a fresh $40M in funding, Letter AI is challenging sales tech incumbents by moving beyond static playbooks to real-time, deal-specific AI guidance.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

A 20-year fight to save Nova Scotia salmon from acid rain is now a certified climate technology, attracting major investment and creating a new model for conservation.

A new GenAI chatbot is replacing frustrating product manuals, earning a top award and signaling a major shift in customer experience for retail.